XTALPI (02228) Names Zhou Feiran as Chief Financial Officer, Effective 10 March 2026

Bulletin Express
03/10

XtalPi Holdings Limited (stock code: 02228) has appointed Mr. Zhou Feiran as Chief Financial Officer, effective 10 March 2026, according to a voluntary announcement released by the Board of Directors.

Mr. Zhou brings more than 12 years of capital-markets and M&A experience in the global healthcare sector. From 2020 to 2026 he served at J.P. Morgan, rising to Executive Director within the Global Healthcare Investment Banking division. Prior roles include Vice President in Global Healthcare Investment Banking at Bank of America Merrill Lynch (2015-2020), as well as positions at a multinational private-equity fund and the advisory division of KPMG Huazhen LLP.

Mr. Zhou holds an MBA from Northwestern University’s Kellogg School of Management and a Bachelor’s degree in Finance from Tongji University. He is a Certified Public Accountant (China) and a Chartered Financial Analyst charter-holder.

The Board—comprising Executive Directors Dr. Wen Shuhao (Chairman), Dr. Ma Jian, Dr. Lai Lipeng and Dr. Jiang Yide Alan, and Independent Non-Executive Directors Mr. Law Cheuk Kin Stephen, Ms. Chan Wing Ki and Mr. Chow Ming Sang—extended a formal welcome to Mr. Zhou on his appointment.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10